Financial Statements

bioMérieux S.A. (BIM.PA)

83.98 €

+1.32 (+1.60%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 404273257238-
Net Income 601404273257238
Stock Dividends -331-250-215-19839
Dividend Paid -73-23-41-40-39
Retained Earnings 601404273257238

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 1,0691,025807712-
Annual Depreciation 446321491323895
Capital Expenditure -290-278-273-227-184
Net PPE 1,2251,0691,025807712

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -443617653629
New Purchases ---2-2-
Intangible and Goodwill 443617653629670

bioMérieux S.A. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes bioMérieux S.A. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.